Revive Therapeutics Stock Working Capital
| RVVTF Stock | USD 0.01 0.0002 4.00% |
Revive Therapeutics fundamentals help investors to digest information that contributes to Revive Therapeutics' financial success or failures. It also enables traders to predict the movement of Revive OTC Stock. The fundamental analysis module provides a way to measure Revive Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Revive Therapeutics otc stock.
Revive |
Revive Therapeutics OTC Stock Working Capital Analysis
Revive Therapeutics' Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current Revive Therapeutics Working Capital | 132 K |
Most of Revive Therapeutics' fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Revive Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
| Competition |
Based on the company's disclosures, Revive Therapeutics has a Working Capital of 132 K. This is 99.97% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The working capital for all United States stocks is 99.99% higher than that of the company.
Revive Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Revive Therapeutics' direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Revive Therapeutics could also be used in its relative valuation, which is a method of valuing Revive Therapeutics by comparing valuation metrics of similar companies.Revive Therapeutics is currently under evaluation in working capital category among its peers.
Revive Fundamentals
| Return On Equity | -0.83 | |||
| Return On Asset | -0.43 | |||
| Current Valuation | 32.12 M | |||
| Shares Outstanding | 353.56 M | |||
| Shares Owned By Insiders | 2.48 % | |||
| Shares Owned By Institutions | 2.42 % | |||
| Price To Earning | (4.10) X | |||
| Price To Book | 4.00 X | |||
| EBITDA | (17.74 M) | |||
| Net Income | (17.81 M) | |||
| Cash And Equivalents | 5.29 M | |||
| Cash Per Share | 0.02 X | |||
| Total Debt | 60 K | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 1.83 X | |||
| Book Value Per Share | 0.03 X | |||
| Cash Flow From Operations | (13.06 M) | |||
| Earnings Per Share | (0.06) X | |||
| Number Of Employees | 16 | |||
| Beta | -0.0535 | |||
| Market Capitalization | 36.1 M | |||
| Total Asset | 17.07 M | |||
| Retained Earnings | (4.38 M) | |||
| Working Capital | 132 K | |||
| Current Asset | 635 K | |||
| Current Liabilities | 503 K | |||
| Net Asset | 17.07 M |
About Revive Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Revive Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Revive Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Revive Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Revive OTC Stock
Revive Therapeutics financial ratios help investors to determine whether Revive OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Revive with respect to the benefits of owning Revive Therapeutics security.